OSMR and breast carcinoma: Conversely, OSMR downregulation by shRNA in CAF-173 delayed tumor onset and tumor growth at early stages when coinjected with MDA-MB-231 breast cancer cells ectopically expressing human OSM (MDA-MB-231-hOSM) (Supplemental Figure 10, A–D).